Company intelligence / Profile preview

Seripharm

Le Mans, Pays de la Loire, France

Ownership: Private
Employees: ~100
Development stage: Other

Overview

Seripharm is a specialized Contract Development and Manufacturing Organization (CDMO) and API manufacturer focused on high-potency active pharmaceutical ingredients (HPAPIs). The company is recognized as a world leader in the production of taxanes, including paclitaxel, docetaxel, and cabazitaxel, which are essential for various oncology treatments. Operating out of its facility in Le Mans, France, Seripharm offers expertise in plant extraction, hemisynthesis, and chromatography-based purification. Since 2022, the company has been part of the Axplora group (formed by the merger of PharmaZell and Novasep), providing end-to-end support from clinical development to commercial supply.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Seripharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Seripharm.

Explore the full profile